Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.16 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.37 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.336EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.317EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.397EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used